STROKESTOP III - Optimized Method for Atrial Fibrillation Screening — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

STROKESTOP III - Optimized Method for Atrial Fibrillation Screening — Stella

Recruiting

Back to Atrial Fibrillation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Sweden

Karolinska Institutet, Dept Med H, Stockholm

Region Värmland, Värmland

Key details

Sponsor

Danderyd Hospital

Collaborators

Karolinska Institutet, Landstinget i Värmland

Enrollment target

~2,200 participants

Started

May 2024

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

75 Years – 76 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov